Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine iliac fascia block and perioperative neurocognitive function in elderly hip fracture
ChiCTR2400084746Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- May 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in hip fracture (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Confusion Assessment Method (CAM) delirium scale, Mini-Mental State Examination (MMSE) and 4 more. Planned start May 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2400084746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084746.